Sodium iodide symporter: Its role in nuclear medicine

Journal of Nuclear Medicine

Volumn 43, Issue 9, 2002, Pages 1188-1200

  Chung, June Key ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Gene therapy; Reporter gene; Sodium iodide symporter; Thyroid carcinoma

Indexed keywords

AUTOANTIBODY; AZACITIDINE; BUTYRIC ACID; DOPAMINE RECEPTOR; IODINE 123; IODINE 125; IODINE 131; ISOTRETINOIN; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; RETINOIC ACID; RHENIUM 188; SODIUM IODIDE SYMPORTER; SODIUM IODIDE SYMPORTER AUTOANTIBODY; TECHNETIUM 99M; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; BREAST CARCINOMA; CELL MEMBRANE TRANSPORT; CLINICAL TRIAL; CONGENITAL HYPOTHYROIDISM; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENE THERAPY; GENE TRANSFER; GRAVES DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; NUCLEAR MEDICINE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; RADIOISOTOPE THERAPY; REGULATORY MECHANISM; REPORTER GENE; STOMACH CARCINOMA; THYROID ADENOMA; THYROID CARCINOMA; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID PAPILLARY CARCINOMA; THYROID SCINTISCANNING; TISSUE DISTRIBUTION;

ANIMALS; BREAST NEOPLASMS; CONGENITAL HYPOTHYROIDISM; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENES, REPORTER; HUMANS; IODINE; IODINE RADIOISOTOPES; MALE; MICE; STOMACH NEOPLASMS; SYMPORTERS; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS; TRANSFECTION;

EID: 0036732003     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Molecular analysis of the sodium/iodide symporter: Impact on thyroid and extrathyroid pathophysiology
2. Cloning and characterization of the thyroid iodide transporter
3. Will radioiodine be useful in treatment of breast cancer?
4. - symporter distribution in human thyroid tissues: An immunohistochemical study
5. - symporter
6. Cloning of the human sodium iodide symporter
7. - symporter (NIS): Recent advances
8. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism
9. The sodium/iodide symporter and its potential role in cancer therapy
10. - symporter with an anti-COOH terminus antibody
11. - symporter mRNAs in dog thyroid
12. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein
13. Regulation and tissue distribution of the human sodium iodide symporter gene
14. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line
15. - symporter gene expression
16. Sodium iodide symporter in health and disease
17. The mammary gland iodide transporter is expressed during lactation and in breast cancer
18. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa
19. Iodide symporter gene expression in normal and transformed rat thyroid cells
20. Differential regulation of the human sodium/iodide symporter gene promoter in papillary thyroid carcinoma cell lines and normal thyroid cells
21. Pax8 has a key role in thyroid cell differentiation
22. Absence of sodium/iodide symporter gene mutations in differentiate human thyroid carcinomas
23. The sodium iodide symporter: Its emerging relevance to clinical thyroidology
24. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells
25. Redifferentiation therapy with retinoids: Therapeutic option for advanced follicular and papillary carcinoma
26. Redifferentiation therapy of thyroid cancer: Results of a multicenter pilot study
27. Redifferentiation therapy-induced radioiodine uptake in thyroid cancer
28. - symporter gene methylation status
29. - symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes
30. Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas
31. - symporter (NIS) in a large sampling of thyroid cancer cases
32. Relationship between differentiation and expression of sodium/iodide symporter or glucose transporter-1 in differentiated thyroid carcinoma
33. 131I whole-body scan
34. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinoma
35. Iodide symporter gene expression in human thyroid tumors
36. Comparison of I-131 diagnostic scan and therapeutic scan in thyroid carcinoma
37. 131I uptake in recurrent lesions of differentiated thyroid carcinoma
38. 125I uptake-blocking activity in breast cancer
39. I-131 total-body scan: Localization of disseminated gastric adenocarcinoma
40. The modulation of the human sodium iodide symporter activity by Graves' disease sera
41. - symporter in the sera of patients with autoimmune thyroid disease
42. - symporter in patients with autoimmune thyroid disease
43. - symporter gene
44. Reestablishment of in vitro and in vivo iodide uptake by transfection of the human sodium iodide symporter (hNIS) in a hNIS defective human thyroid carcinoma cell line
45. Animal model of a human anaplastic thyroid cancer cell line, ARO-N, expressing sodium/iodide symporter
46. - symporters for radioiodide concentrator gene therapy
47. Transfer of the human NaI symporter gene enhances iodide uptake in hepatoma cells
48. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene
49. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy
50. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium/iodide symporter
51. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter
52. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters
53. Ectopic expression of the thyroperoxidase gene augment radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer
54. Rhenium-188 as an alternative to iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS)
55. Functional genomics and proteomics: The role of nuclear medicine
56. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
57. The possibility of sodium/iodide symporter (NIS) gene as a new imaging reporter gene system
58. Monitoring of neural stem cell using sodium/iodide symporter gene